Stay updated on Nivolumab + Celecoxib in Cold Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page.

Latest updates to the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page
- Check4 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a backend/content update rather than a change to the study information presented.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision has been updated from v3.6.3 to v3.6.4, indicating a minor CMS or rendering update to the study details page. This change does not modify the study information or user-facing content.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page's revision tag was updated to v3.6.3, representing a small, internal update to the page's version history rather than a change to study details or user-facing content.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page's revision label updated from v3.6.0 to v3.6.2, reflecting a newer version of the page’s underlying software.SummaryDifference0.1%

- Check61 days agoChange DetectedNew help and navigation items were added to the study record page (How to Read a Study Record, Common Questions, How to Join a Study) and several labels were revised (Last verified, Last known status was), with the Intervention label updated from 'Intervention / Treatment' to 'Intervention/Treatment' and a new revision note 'Revision: v3.6.0' appeared.SummaryDifference2%

- Check68 days agoChange DetectedRevision: v3.5.5 is now shown in the release notes, replacing v3.5.4. This reflects a minor website software update and does not alter the study details or user actions on the page.SummaryDifference0.1%

Stay in the know with updates to Nivolumab + Celecoxib in Cold Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Celecoxib in Cold Tumors Clinical Trial page.